Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates.
about
Polymer-drug conjugates: origins, progress to date and future directionsTwo-step fluorescence screening of CD21-binding peptides with one-bead one-compound library and investigation of binding properties of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugatesCombination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cellsHPMA copolymers: origins, early developments, present, and future.Macromolecular therapeuticsCombination drug delivery approaches in metastatic breast cancerBiological rationale for the design of polymeric anti-cancer nanomedicines.Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.POLYMERIC BIOMATERIALS AND NANOMEDICINES.Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugsPolymer conjugates as anticancer nanomedicines.Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel.Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cellsBiorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cells.Indium-based and iodine-based labeling of HPMA copolymer-epirubicin conjugates: Impact of structure on the in vivo fate.Photosensitiser-antibody conjugates for photodynamic therapy.Recent advances in drug delivery strategies for treatment of ovarian cancer.Immunoconjugates and long circulating systems: origins, current state of the art and future directionsPolymeric micelles: nanocarriers for cancer-targeted drug deliveryRole of polymer-drug conjugates in organ-specific delivery systems.Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.Coumarin-containing-star-shaped 4-arm-polyethylene glycol: targeted fluorescent organic nanoparticles for dual treatment of photodynamic therapy and chemotherapy.Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivoSynthesis and in vitro anticancer activity of zinc(II) phthalocyanines conjugated with coumarin derivatives for dual photodynamic and chemotherapy.HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition.Neuroendocrine Tumor-Targeted Upconversion Nanoparticle-Based Micelles for Simultaneous NIR-Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging.The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment.Water-soluble complex formation of fullerene and thermo-responsive diblock copolymerSynthetic polymers as drugs and therapeuticsEnhancing the Delivery of Chemotherapeutics: Role of Biodegradable Polymeric Nanoparticles
P2860
Q27002505-1A853C1A-AD03-4814-BD3A-E19925AD7938Q33263225-10329981-D729-4021-9A13-0263B41EDA19Q33670961-D5619197-D61B-46B2-A6CA-C63D800CA4D0Q33719148-5DC0D799-63A4-44D7-8B4F-578E22E0C377Q34079574-6CB7DC85-B109-4395-B741-A131053F8F31Q35955198-B47A6B08-E9DF-4D77-B922-48DD560589D6Q36160333-81829A84-E527-4C4F-93FF-EFE671AD63AFQ36160805-060EA39B-672F-4D40-893D-C0ECCD84497CQ36376467-C0F87957-77EF-4A69-BCA0-17C713E388FBQ36502354-AB2B875E-92D3-4CB3-B260-B7D8452E8C82Q36561667-F3F9F6F5-933C-4915-9FA6-60B84FCE4742Q36589127-90A43504-BC5F-450F-B861-62422DC8328BQ37107517-74EFB3A2-5F24-402C-8BC7-71747FF5CF6BQ37218120-FF11E1CF-CE15-4914-A9A7-9CEBA84968BCQ37334071-2A93F1F7-D9CB-4D9C-A840-FCB5930CBAE3Q37853421-E8CA11E9-95B4-4C65-ABF7-84BA38CE31D9Q37997512-1E5DE242-0059-4030-9F70-89E0088CF54FQ38042256-0ECCD338-A13F-4F93-A232-3E1CFEC9954CQ38202058-EC7D4DA7-999B-40A5-B9C3-BA0EBB3105EEQ38365556-BA429AE8-50EE-4B8F-8266-4774ACFA008FQ38741016-B9C32842-0261-4884-A6E1-895077FBB3A4Q38864976-7B712FA3-89C1-4043-BE6C-926411D8B362Q38867245-E595D510-B0A9-4CB8-A31C-25C99CB1C1DDQ38942834-4696E360-1BDC-4CAC-91DD-67E98690729AQ39096548-F3104A35-E0FF-42DF-9023-6435CF8585F4Q40210611-AC23AD46-E6A9-4DC8-A774-82E00F2B922BQ42011249-FF19A030-8E08-4684-84C5-9744090FA1E2Q48558433-831273F3-1564-48AF-AF22-78A1320D951EQ57345025-25EE9399-9FEA-4263-88FC-0312932123F5Q57370215-ECFBF208-8A56-4081-A068-056DC51B5B86Q58696611-D5BCD341-A4BA-49C0-BC02-D3BCEABED3F1
P2860
Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Combination chemotherapy and p ...... 16 antibody immunoconjugates.
@ast
Combination chemotherapy and p ...... 16 antibody immunoconjugates.
@en
type
label
Combination chemotherapy and p ...... 16 antibody immunoconjugates.
@ast
Combination chemotherapy and p ...... 16 antibody immunoconjugates.
@en
prefLabel
Combination chemotherapy and p ...... 16 antibody immunoconjugates.
@ast
Combination chemotherapy and p ...... 16 antibody immunoconjugates.
@en
P2093
P1476
Combination chemotherapy and p ...... 16 antibody immunoconjugates.
@en
P2093
P304
P356
10.1016/S0168-3659(01)00325-X
P407
P577
2001-07-01T00:00:00Z